10x Genomics（TXG）：股价一个月反弹36%后估值评估 - simplywall.st
10x Genomics (TXG): Assessing Valuation After a 36% One-Month Share Price Rebound - simplywall.st
生命科学资讯
生物技术与制药领域的最新动态
10x Genomics (TXG)：股价一个月反弹36%后的估值评估 - simplywall.st
10x Genomics (TXG): Assessing Valuation After a 36% One-Month Share Price Rebound - simplywall.st
为何分析师青睐10x Genomics股票——2025年7月市场反应与低风险入场指南
Why 10x Genomics Inc. stock appeals to analysts - July 2025 Reactions & Low Risk Entry Point Guides - Newser
重新审视10x Genomics（TXG）：近期股价反弹是否已充分反映其增长潜力？——雅虎财经
Rethinking 10x Genomics (TXG): Is the Recent Share Price Rebound Already Pricing In Its Growth Potential? - Yahoo Finance
重新审视10x Genomics (TXG)：近期股价反弹是否已充分反映其增长潜力？ - 雅虎财经英国
Rethinking 10x Genomics (TXG): Is the Recent Share Price Rebound Already Pricing In Its Growth Potential? - Yahoo Finance UK
Russell Investments Group Ltd.增持10x Genomics $TXG股份 - MarketBeat
Russell Investments Group Ltd. Increases Stock Position in 10x Genomics $TXG - MarketBeat
值得关注的股票：10x Genomics相对强度评级升至91分 - MSN
Stocks To Watch: 10x Genomics Sees Relative Strength Rating Rise To 91 - MSN
下一代测序文库制备市场 - openPR.com
Next Generation Sequencing Library Preparation Market - openPR.com
三只基本面存疑且持续亏损的股票 - 雅虎财经
3 Unprofitable Stocks with Questionable Fundamentals - Yahoo Finance
人类单细胞多组学市场预计将迎来快速增长， - openPR.com
Human Single-Cell Multi-Omics Market Set for Rapid Growth, - openPR.com
10x Genomics就第二项UPC初步禁令决定发表评论 - GuruFocus
10x Genomics Comments on Second UPC Preliminary Injunction Decis - GuruFocus
摩根士丹利下调10x Genomics评级，同时上调目标价 | TXG股票新闻 - GuruFocus
TXG: Morgan Stanley Downgrades 10x Genomics, Raises Price Target | TXG Stock News - GuruFocus
摩根士丹利下调10x Genomics评级，同时上调目标价
TXG: Morgan Stanley Downgrades 10x Genomics, Raises Price Target - GuruFocus
10x Genomics Inc. (1KJ)股票是否被低估？——收益增长报告与高回报股票监控提醒
Is 10x Genomics Inc. (1KJ) stock cheap vs fundamentals - Earnings Growth Report & High Return Stock Watch Alerts - Newser
摩根士丹利将10x Genomics评级从增持下调至平配，目标价从17美元上调至20美元——市场观察者
Morgan Stanley Downgrades 10x Genomics to Equalweight From Overweight, Lifts Price Target to $20 From $17 - MarketScreener
摩根士丹利对10X Genomics股票给予“等权重”评级，开始覆盖 - Investing.com
Morgan Stanley assumes coverage on 10X Genomics stock with Equalweight rating - Investing.com
摩根士丹利将10x Genomics评级从增持下调至平配
10x Genomics downgraded to Equal Weight from Overweight at Morgan Stanley - TipRanks
摩根士丹利对10X Genomics股票给予等权重评级，开始覆盖研究 - Investing.com
Morgan Stanley assumes coverage on 10X Genomics stock with Equalweight rating - Investing.com
摩根斯坦利将10x Genomics评级从增持下调至中性
10x Genomics assumed at Equal Weight from Overweight at Morgan Stanley - TipRanks
研究比较新兴液滴式单细胞RNA测序平台与10x Genomics系统的性能表现 - geneonline.com
Study Compares Performance of Emerging Droplet-Based scRNA-seq Platforms to 10x Genomics System - geneonline.com